Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arrowhead Pharmaceuticals (ARWR)
Technical Analysis Report for NASDAQ stock ARWR Arrowhead Pharmaceuticals. Dated: 23 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ARWR Arrowhead Pharmaceuticals then click here. or read Experts views on Arrowhead Pharmaceuticals or Forecast & share price targets of Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals Opened at 57.16 and Closed at: 56.67, which is 0.67% of previous session's close. It moved within a range of 56.24 and 58.64
The session was a Bearish session with an average volume of 2001200, which is 35.38% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 55.26 and resistance for tomorrow is 57.66
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 55.73, 54.78 resistance for tomorrow's hourly charts is 58.13, 59.58
10 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 57.29 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 60.25 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arrowhead Pharmaceuticals (ARWR) is 63.58 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 59.49 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Arrowhead Pharmaceuticals is 41.69 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Arrowhead Pharmaceuticals is at 60.25 and 200 DMA is at 41.69, while 50 DMA and 100 DMA are at 63.58 and 59.49 respectively
Arrowhead Pharmaceuticals (ARWR) moving average of 20 SMA is at 60.25 and 20 EMA is at 59.52
| Date | Closing Price | 20 SMA | 20 EMA |
| 23 Mon Mar | 56.67 | 60.25 | 59.52 |
| 20 Fri Mar | 56.29 | 60.59 | 59.82 |
| 19 Thu Mar | 56.93 | 60.97 | 60.19 |
| 17 Tue Mar | 57.57 | 61.34 | 60.53 |
| 16 Mon Mar | 57.37 | 61.65 | 60.84 |
| 13 Fri Mar | 55.05 | 61.97 | 61.21 |
Arrowhead Pharmaceuticals (ARWR) moving average of 50 SMA is at 63.58 and 50 EMA is at 61.13
| Date | Closing Price | 50 SMA | 50 EMA |
| 23 Mon Mar | 56.67 | 63.58 | 61.13 |
| 20 Fri Mar | 56.29 | 63.75 | 61.31 |
| 19 Thu Mar | 56.93 | 63.94 | 61.51 |
| 17 Tue Mar | 57.57 | 64.22 | 61.7 |
| 16 Mon Mar | 57.37 | 64.34 | 61.87 |
| 13 Fri Mar | 55.05 | 64.55 | 62.05 |
Arrowhead Pharmaceuticals (ARWR) moving average of 100 SMA is at 59.49 and 100 EMA is at 56.84
| Date | Closing Price | 100 SMA | 100 EMA |
| 23 Mon Mar | 56.67 | 59.49 | 56.84 |
| 20 Fri Mar | 56.29 | 59.31 | 56.84 |
| 19 Thu Mar | 56.93 | 59.13 | 56.85 |
| 17 Tue Mar | 57.57 | 58.94 | 56.85 |
| 16 Mon Mar | 57.37 | 58.74 | 56.84 |
| 13 Fri Mar | 55.05 | 58.54 | 56.83 |
Arrowhead Pharmaceuticals (ARWR) moving average of 200 SMA is at 41.69 and 200 EMA is at 47.16
| Date | Closing Price | 200 SMA | 200 EMA |
| 23 Mon Mar | 56.67 | 41.69 | 47.16 |
| 20 Fri Mar | 56.29 | 41.49 | 47.06 |
| 19 Thu Mar | 56.93 | 41.29 | 46.97 |
| 17 Tue Mar | 57.57 | 41.09 | 46.87 |
| 16 Mon Mar | 57.37 | 40.88 | 46.76 |
| 13 Fri Mar | 55.05 | 40.67 | 46.65 |
Dentsply Sirona has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Dentsply Sirona, about 2.2% more returns!
Vertex Pharmaceuticals has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Vertex Pharmaceuticals, about 4.06% more returns!
Sarepta Therapeutics has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Sarepta Therapeutics, about 7.99% more returns!
Arrowhead Pharmaceuticals has performed better than Soleno Therapeutics in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Rigel Pharmaceuticals in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Ocular Therapeutix has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Ocular Therapeutix, about 6.56% more returns!
National Research has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in National Research, about 50.33% more returns!
Arrowhead Pharmaceuticals has performed better than Neogen Corporation in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Nature S in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Mesoblast in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Orthopediatrics Corp has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Orthopediatrics Corp, about 11.29% more returns!
Arrowhead Pharmaceuticals has performed better than Adma Biologics in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Anixa Biosciences in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Ascendis Pharma has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Ascendis Pharma, about 3.06% more returns!
Aytu Bioscience has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Aytu Bioscience, about 26.11% more returns!
Arrowhead Pharmaceuticals has performed better than Collegium Pharmaceutical in short term. Holding Arrowhead Pharmaceuticals could be a better choice for now!
Healthcare Services has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Healthcare Services, about 4.1% more returns!
Healthways Inc has performed better than Arrowhead Pharmaceuticals in short term. You could have earned much better returns by investing in Healthways Inc, about 1.15% more returns!
Arrowhead Pharmaceuticals Technical analysis of indicators
Price action analysis of Arrowhead Pharmaceuticals (ARWR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Arrowhead Pharmaceuticals in short term and the sell signal is strong.
Arrowhead Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arrowhead Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 56.92 and Arrowhead Pharmaceuticals ARWR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arrowhead Pharmaceuticals ARWR stock. Volume based technical analysis of Arrowhead Pharmaceuticals ARWR stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock ARWR Arrowhead Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ARWR Experts View which covers a lot of information including buying and selling signals
ARWR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arrowhead Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arrowhead Pharmaceuticals (ARWR) Technical (Analysis) Reports Arrowhead Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


